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Recent work fromKuehner and Brow (2008) and Thiebaut et al. (2008) inMolecular Cell and Jenks et al. (2008)
inMolecular and Cellular Biology reveals that regulated expression of central nucleotide synthesis pathway
components directs start site-dependent RNA polymerase II termination.Transcription by RNA polymerase II (Pol II)
comprises cycles of initiation, elongation,
and termination. Although RNA synthesis
is controlled in many instances at the
step of initiation at gene promoters, post-
initiation events also contribute essential
layers of regulation. A striking example
of this is the recent discovery of hundreds
of cryptic unstable transcripts (CUTs) that
are transcribed by Pol II in yeast (Wyers
et al., 2005). CUTs are frequently derived
from intergenic regions and normally do
not accumulate in significant amounts at
steady state. Notably, the mode of termi-
nation associated with CUT transcription
is a major determinant for their instability.
Two major pathways are known to end
processive RNA synthesis by Pol II in
yeast (reviewed in Lykke-Andersen and
Jensen, 2007). In both cases, the interac-
tion of termination factors with both Pol II
and the nascent RNA are important, but
distinct classes of transcripts are af-
fected. One pathway produces mostly
protein-encoding mRNA, is guided
by poly(A) signals, and relies on the ca-
nonical pre-mRNA 30 end formation
machinery. The other pathway acts pre-
dominately on small nucleolar RNAs
(snoRNAs) and CUTs and depends on
the Nrd1 complex, which is constituted
by the RNA-binding proteins Nrd1 and
Nab3 and the helicase Sen1. Interestingly,
transcripts terminated via the Nrd1 com-
plex are frequently targeted by the nuclear
exosome, a 30–50 exonuclease complex.
In this way snoRNAs receive some 30
end trimming, whereas CUTs will be effi-
ciently degraded (Thiebaut et al., 2006;
Arigo et al., 2006).
Recent reports by Kuehner and Brow
(2008), Thiebaut et al. (2008), and Jenks
et al. (2008) established an intriguing con-
cept of transcriptional regulation that inte-
grates essential aspects of initiation andtermination in yeast. The Brow and Reines
labs dissected the mechanisms govern-
ing IMD2 expression. This gene encodes
the inosine monophosphate dehydroge-
nase (IMPDH) that catalyzes the first step
in GMP biosynthesis. Its expression is in-
versely correlated with the availability of
GTP, but how the cell senses nucleotide
levels remained obscure. Remarkably,
IMD2 transcripts originate from alterna-
tive start sites under control of a single up-
stream promoter (TATA box; Figure 1A).
Kuehner and Brow (2008) demonstrate
that RNA obtained in the presence of am-
ple GTP started with guanosine (G) at the
first position, whereas reduced levels of
GTP gave RNAs starting more distal to the
promoter with adenosine (A). This finding
nicely fits the previous proposal by the
Brow lab that Pol II scans along the
IMD2 promoter and that sequence con-
text as well as GTP concentration consti-
tutes a switch that eventually determines
the start site (Steinmetz et al., 2006). The
G-site-dependent RNAs contain a Sen1-
dependent terminator; consequently,
these transcripts are rapidly degraded
by the exosome and represent bona fide
CUTs. Remarkably, the terminator is ex-
cluded when Pol II scanning favors the
A-site to start RNA synthesis under low
GTP conditions. This facilitates transcrip-
tion of the entire IMD2 gene, poly(A)-de-
pendent termination, and production of
functional mRNA. Thus, the GTP-depen-
dent selection of the start site regulates
the mode of Pol II termination and, with
it, the fate of IMD2-associated transcripts.
Is this control mechanism of more gen-
eral relevance? Certain aspects are, e.g.,
the architecture of the regulatory region:
the URA2 gene encodes an enzyme in-
volved in pyrimidine biosynthesis that is
regulated by uracil availability, and Thie-
baut et al. (2008) show that a single pro-Molecular Cell 31,moter (TATA box) controls URA2 start
sites, which are separated by a Nrd1
dependent terminator (Figure 1B). In con-
trast to IMD2, however, the authors ob-
served constitutive expression of the up-
stream CUT independent of uracil levels,
whereas URA2 mRNA transcription was
strongly stimulated by low uracil. The
identity of the starting nucleotide plays
no discernable role in start site choice, ar-
guing against UTP-dependent Pol II initia-
tion. Moreover, Thiebaut et al. (2008)
show that reduced CUT expression is
not a prerequisite for mRNA transcription.
Start site-dependent termination at the
URA2 locus therefore does not direct
the mutually exclusive production of ei-
ther CUTs or mRNA as was observed for
IMD2. Libri and colleagues suggest in-
stead that the URA2 CUT might modulate
the transcriptional response to reduced
nucleotide levels. Activation requires that
some scanning Pol II molecules skip the
CUT start site and initiate transcription
downstream of the terminator. Thiebaut
et al. (2008) identified the R box, a T-rich
regulatory element, as an essential compo-
nent of this process. The mechanistic de-
tails remain unclear, but the R box might
enhance skipping of the CUT site or oth-
erwise promote the usage of the mRNA
start site. Although several possible sce-
narios for activation could be discussed,
an important piece of theURA2 regulation
puzzle is still missing: the mechanism of
metabolite sensing. Thiebaut et al. (2008)
point out, however, that a major function
of the URA2 CUT could be to maintain
low basal levels ofURA2mRNA transcrip-
tion in the presence of ample uracil by
‘‘trapping’’ initiated Pol II in a cycle of un-
productive transcription. Low levels of
uracil might interrupt this cycle to facili-
tate a rapid transcriptional induction of
the URA2 mRNA.September 5, 2008 ª2008 Elsevier Inc. 617
Molecular Cell
PreviewsFigure 1. Regulation of IMD2 and URA2 Genes Involved in Nucleotide Biosynthesis
Schematic representation (not in scale) of regulatory elements involved in start site-dependent transcrip-
tional termination. Both IMD2 (A) and URA2 (B) genes display a similar organization. Alternative transcrip-
tion start sites, which are under control of a single promoter (TATA), are separated by a transcriptional
terminator that is recognized by the Nrd1 complex. GTP levels regulate start selection by scanning Pol II
at upstream G sites or a downstream A site of the IMD2 gene. This results in the synthesis of CUTs that
are rapidly degraded by the exosome or of functional mRNA, respectively. By contrast, CUT transcription
is constitutive at URA2, i.e., independent of uracil level. URA2 mRNA transcription, however, is
dependent on low uracil, CUT transcription, and the R box, a T-rich sequence that is associated with
the terminator.Notably, upstream CUTs are associ-
ated with several other genes (URA8,
ADE12, and IMD3) involved in nucleotide
biosynthesis (Thiebaut et al., 2008), sug-
gesting regulatory mechanisms similar
to the examples discussed above. Tran-618 Molecular Cell 31, September 5, 2008 ªscription attenuation, i.e., regulated termi-
nation and antitermination, is a wide-
spread strategy to control gene expres-
sion in bacteria (Henkin and Yanofsky,
2002). The papers discussed here might
point to a prevalence of attenuation also2008 Elsevier Inc.in eukaryotic cells. Start site-dependent
Pol II transcription termination is closely
associated with CUT metabolism. Con-
sidering the central role of the nascent
transcript during termination, CUTs could
be viewed as RNA elements mediating
Pol II termination rather than simply being
an ‘‘undesired’’ product of the transcrip-
tional process. Attenuation, therefore,
extends the growing functional repertoire
of CUTs and CUT transcription, respec-
tively.
REFERENCES
Arigo, J.T., Eyler, D.E., Carroll, K.L., and Corden,
J.L. (2006). Mol. Cell 23, 841–851.
Henkin, T.M., and Yanofsky, C. (2002). Bioessays
24, 700–707.
Jenks, M.H., O’Rourke, T.W., and Reines, D.
(2008). Mol. Cell. Biol. 28, 3883–3893.
Kuehner, J.N., and Brow, D.A. (2008). Mol. Cell 31,
201–211.
Lykke-Andersen, S., and Jensen, T.H. (2007). Bio-
chimie 89, 1177–1182.
Steinmetz, E.J., Warren, C.L., Kuehner, J.N., Pan-
behi, B., Ansari, A.Z., and Brow, D.A. (2006). Mol.
Cell 24, 735–746.
Thiebaut, M., Kisseleva-Romanova, E., Rouge-
maille, M., Boulay, J., and Libri, D. (2006). Mol.
Cell 23, 853–864.
Thiebaut, T., Colin, J., Neil, H., Jacquier, A., Se´ra-
phin, B., Lacroute, F., and Libri, D. (2008). Mol.
Cell 31, this issue, 671–682.
Wyers, F., Rougemaille, M., Badis, G., Rousselle,
J.C., Dufour, M.E., Boulay, J., Regnault, B., De-
vaux, F., Namane, A., Seraphin, B., et al. (2005).
Cell 121, 725–737.
